» Authors » C W Moore

C W Moore

Explore the profile of C W Moore including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 390
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Moore C, Allen J
J Prim Prev . 2013 Nov; 17(2):231-58. PMID: 24254961
This article reviews some of the best researched volunteer service programs for adolescents and addresses three major questions: 1) What do existing data tell us about the effectiveness of community...
2.
Moore C, Rauch P
Bone Marrow Transplant . 2006 Oct; 38(12):775-82. PMID: 17041607
Although a significant number of adults undergoing stem cell transplant (SCT) or bone marrow transplantation (BMT) care for dependent children, and these treatments pose significant challenges for families, research has...
3.
Martinez M, Pramanik A, McKoy J, Robert K, Moore C
Cell Mol Biol (Noisy-le-grand) . 2003 Dec; 49(7):1049-56. PMID: 14682386
Mutational alteration of the BLM5 gene of the model eukaryote, Saccharomyces cerevisiae, confers extreme hypersensitivities to lethal effects of ionizing radiation, anticancer bleomycins and structurally-related phleomycins. Additional properties conferred by...
4.
Martinez M, Pramanik A, Moto-Ndje S, Moore C
Cell Mol Biol (Noisy-le-grand) . 2003 Dec; 49(7):1025-35. PMID: 14682384
Anticancer bleomycins and structurally-related analogs are oxidative agents that mimic ionizing radiation in many of their cellular effects. The current study was designed to better understand this class of radiomimetic...
5.
Febres D, Pramanik A, Caton M, Doherty K, McKoy J, Garcia E, et al.
Cell Mol Biol (Noisy-le-grand) . 2002 Feb; 47(7):1149-62. PMID: 11842813
Mutational alteration of the BLM3 gene in Saccharomyces cerevisiae confers hypersensitivities to lethal effects of ionizing radiation, anticancer bleomycins and structurally-related phleomycins. Bleomycin is used clinically in the treatment of...
6.
Schroeder M, Hamby J, CONNOLLY C, Grohar P, Winters R, Barvian M, et al.
J Med Chem . 2001 Jun; 44(12):1915-26. PMID: 11384237
In continuing our search for medicinal agents to treat proliferative diseases, we have discovered 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas as a novel class of soluble, potent, broadly active tyrosine kinase (TK) inhibitors....
7.
Kraker A, Hartl B, Amar A, Barvian M, Showalter H, Moore C
Biochem Pharmacol . 2000 Sep; 60(7):885-98. PMID: 10974196
Increased expression or activity of c-Src tyrosine kinase has been associated with the transformed phenotype in tumor cells and with progression of neoplastic disease. A number of pyrido[2, 3-d]pyrimidines have...
8.
Moore C, McKoy J, Dardalhon M, Davermann D, Martinez M, Averbeck D
Genetics . 2000 Apr; 154(3):1085-99. PMID: 10757755
Chromosomal repair was studied in stationary-phase Saccharomyces cerevisiae, including rad52/rad52 mutant strains deficient in repairing double-strand breaks (DSBs) by homologous recombination. Mutant strains suffered more chromosomal fragmentation than RAD52/RAD52 strains...
9.
Ovalle R, Lim S, Holder B, Jue C, Moore C, Lipke P
Yeast . 1998 Oct; 14(13):1159-66. PMID: 9791887
The rate of formation of spheroplasts of yeast can be used as an assay to study the structural integrity of cell walls. Lysis can be measured spectrophotometrically in hypotonic solution...
10.
Pramanik A, Garcia E, Ospina R, Powell M, Martinez M, Alejo W, et al.
Cell Mol Biol (Noisy-le-grand) . 1998 Feb; 43(7):1007-18. PMID: 9449533
The vast majority of AIDS-related deaths are associated with opportunistic infections. For fungal infections, there are few effective antifungals, particularly for systemic use. The discovery that very low doses of...